BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 12692835)

  • 21. Differences in survivin location and Bcl-2 expression in CD30+ lymphoproliferative disorders of the skin compared with systemic anaplastic large cell lymphomas: an immunohistochemical study.
    Goteri G; Simonetti O; Rupoli S; Piccinini G; Rubini C; Stramazzotti D; Fazioli F; Capomagi C; Leoni P; Offidani AM; Lo Muzio L
    Br J Dermatol; 2007 Jul; 157(1):41-8. PubMed ID: 17484779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials.
    Sibon D; Fournier M; Brière J; Lamant L; Haioun C; Coiffier B; Bologna S; Morel P; Gabarre J; Hermine O; Sonet A; Gisselbrecht C; Delsol G; Gaulard P; Tilly H
    J Clin Oncol; 2012 Nov; 30(32):3939-46. PubMed ID: 23045585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
    Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
    Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
    Hsu FY; Johnston PB; Burke KA; Zhao Y
    Cancer Res; 2006 Sep; 66(18):9002-8. PubMed ID: 16982741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of primary cutaneous anaplastic large cell lymphoma with variant anaplastic lymphoma kinase translocation.
    Sasaki K; Sugaya M; Fujita H; Takeuchi K; Torii H; Asahina A; Tamaki K
    Br J Dermatol; 2004 Jun; 150(6):1202-7. PubMed ID: 15214912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaplastic large cell lymphoma, ALK-positive.
    Ferreri AJ; Govi S; Pileri SA; Savage KJ
    Crit Rev Oncol Hematol; 2012 Aug; 83(2):293-302. PubMed ID: 22440390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis.
    Beylot-Barry M; Lamant L; Vergier B; de Muret A; Fraitag S; Delord B; Dubus P; Vaillant L; Delaunay M; MacGrogan G; Beylot C; de Mascarel A; Delsol G; Merlio JP
    Am J Pathol; 1996 Aug; 149(2):483-92. PubMed ID: 8701987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clusterin is widely expressed in systemic anaplastic large cell lymphoma but fails to differentiate primary from secondary cutaneous anaplastic large cell lymphoma.
    Lae ME; Ahmed I; Macon WR
    Am J Clin Pathol; 2002 Nov; 118(5):773-9. PubMed ID: 12428799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders.
    Drakos E; Leventaki V; Schlette EJ; Jones D; Lin P; Medeiros LJ; Rassidakis GZ
    Am J Surg Pathol; 2007 Mar; 31(3):447-53. PubMed ID: 17325487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology.
    Jaffe ES
    Mod Pathol; 2001 Mar; 14(3):219-28. PubMed ID: 11266530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma.
    ten Berge RL; Meijer CJ; Dukers DF; Kummer JA; Bladergroen BA; Vos W; Hack CE; Ossenkoppele GJ; Oudejans JJ
    Blood; 2002 Jun; 99(12):4540-6. PubMed ID: 12036886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study.
    Lamant L; McCarthy K; d'Amore E; Klapper W; Nakagawa A; Fraga M; Maldyk J; Simonitsch-Klupp I; Oschlies I; Delsol G; Mauguen A; Brugières L; Le Deley MC
    J Clin Oncol; 2011 Dec; 29(35):4669-76. PubMed ID: 22084369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma presenting as a bladder neoplasm.
    Gómez-Román JJ; Cobo ML; Val-Bernal JF
    Pathol Int; 2008 Apr; 58(4):249-52. PubMed ID: 18324919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of MUC-1 expression in systemic anaplastic large cell lymphoma.
    Rassidakis GZ; Goy A; Medeiros LJ; Jiang Y; Thomaides A; Remache Y; Cabanillas F; Sarris AH; Gilles F
    Clin Cancer Res; 2003 Jun; 9(6):2213-20. PubMed ID: 12796388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ALK-negative systemic intravascular anaplastic large cell lymphoma presenting in the skin.
    Rieger KE; Polidore T; Warnke R; Kim J
    J Cutan Pathol; 2011 Feb; 38(2):216-20. PubMed ID: 20236372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization.
    Shin HJ; Thorson P; Gu J; Katz RL
    Diagn Cytopathol; 2003 Aug; 29(2):61-6. PubMed ID: 12889041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas.
    Salaverria I; Beà S; Lopez-Guillermo A; Lespinet V; Pinyol M; Burkhardt B; Lamant L; Zettl A; Horsman D; Gascoyne R; Ott G; Siebert R; Delsol G; Campo E
    Br J Haematol; 2008 Mar; 140(5):516-26. PubMed ID: 18275429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphohistiocytic anaplastic large cell lymphoma involving skin: a diagnostic challenge.
    Chuang SS; Hsieh YC; Ye H; Hwang WS
    Pathol Res Pract; 2009; 205(4):283-7. PubMed ID: 19091487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical analysis of primary systemic anaplastic large cell lymphoma: a report of 57 cases.
    Wang FH; Li YH; Zeng J; Rao HL; Xia ZJ; Sun XF; Huang HQ; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2009 Jan; 28(1):49-53. PubMed ID: 19448428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation.
    Rassidakis GZ; Jones D; Lai R; Ramalingam P; Sarris AH; McDonnell TJ; Medeiros LJ
    J Pathol; 2003 Jun; 200(2):240-8. PubMed ID: 12754745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.